Goldman Sachs initiated coverage of Dutch Bros Inc. (NYSE:BROS) with a “neutral” rating and a 12-month price target of $75, offering a 9.4% upside from the June 25 closing price of $68.55.

A racket now under police scrutiny has led to the arrest of seven individuals and the investigation of over 32 government doctors for allegedly altering death reports for money.